From nanotechnology to nanomedicine: applications to cancer research

R. Seigneuric; L. Markey; D.S. Nuyten; C. Dubernet; C.T.A. Evelo; E. Finot; C. Garrido

doi:10.2174/156652410792630634

From nanotechnology to nanomedicine: applications to cancer research

R. Seigneuric^*
, L. Markey
, D.S. Nuyten
, C. Dubernet
, C.T.A. Evelo
, E. Finot
, C. Garrido

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

306 Downloads (Pure)

Abstract

Scientific advances have significantly improved the practice of medicine by providing objective and quantitative means for exploring the human body and disease states. These innovative technologies have already profoundly improved disease detection, imaging, treatment and patient follow-up. Today's analytical limits are at the nanoscale level (one-billionth of a meter) enabling a detailed exploration at the level of DNA, RNA, proteins and metabolites which are in fact nano-objects. This translational review aims at integrating some recent advances from micro- and nano-technologies with high potential for improving daily oncology practice.

Original language	English
Pages (from-to)	640-652
Number of pages	13
Journal	Current Molecular Medicine
Volume	10
Issue number	7
DOIs	https://doi.org/10.2174/156652410792630634
Publication status	Published - Oct 2010

Keywords

Nanomedicine
circulating tumour cell
nanoparticle
EPR effect
CIRCULATING TUMOR-CELLS
METASTATIC BREAST-CANCER
RESISTANT PROSTATE-CANCER
GENE-EXPRESSION
DRUG-DELIVERY
SOLID TUMORS
MICROFLUIDIC DEVICES
DIAGNOSTIC MARKER
ADHESION MOLECULE
PEPTIDE APTAMERS

Access to Document

10.2174/156652410792630634

Full TextFinal published version, 693 KBLicence: Taverne

Cite this

@article{ea5f96e5817847ba9e4d6fff1162b69a,

title = "From nanotechnology to nanomedicine: applications to cancer research",

abstract = "Scientific advances have significantly improved the practice of medicine by providing objective and quantitative means for exploring the human body and disease states. These innovative technologies have already profoundly improved disease detection, imaging, treatment and patient follow-up. Today's analytical limits are at the nanoscale level (one-billionth of a meter) enabling a detailed exploration at the level of DNA, RNA, proteins and metabolites which are in fact nano-objects. This translational review aims at integrating some recent advances from micro- and nano-technologies with high potential for improving daily oncology practice.",

keywords = "Nanomedicine, circulating tumour cell, nanoparticle, EPR effect, CIRCULATING TUMOR-CELLS, METASTATIC BREAST-CANCER, RESISTANT PROSTATE-CANCER, GENE-EXPRESSION, DRUG-DELIVERY, SOLID TUMORS, MICROFLUIDIC DEVICES, DIAGNOSTIC MARKER, ADHESION MOLECULE, PEPTIDE APTAMERS",

author = "R. Seigneuric and L. Markey and D.S. Nuyten and C. Dubernet and C.T.A. Evelo and E. Finot and C. Garrido",

year = "2010",

month = oct,

doi = "10.2174/156652410792630634",

language = "English",

volume = "10",

pages = "640--652",

journal = "Current Molecular Medicine",

issn = "1566-5240",

publisher = "Bentham Science Publishers",

number = "7",

}

TY - JOUR

T1 - From nanotechnology to nanomedicine: applications to cancer research

AU - Seigneuric, R.

AU - Markey, L.

AU - Nuyten, D.S.

AU - Dubernet, C.

AU - Evelo, C.T.A.

AU - Finot, E.

AU - Garrido, C.

PY - 2010/10

Y1 - 2010/10

N2 - Scientific advances have significantly improved the practice of medicine by providing objective and quantitative means for exploring the human body and disease states. These innovative technologies have already profoundly improved disease detection, imaging, treatment and patient follow-up. Today's analytical limits are at the nanoscale level (one-billionth of a meter) enabling a detailed exploration at the level of DNA, RNA, proteins and metabolites which are in fact nano-objects. This translational review aims at integrating some recent advances from micro- and nano-technologies with high potential for improving daily oncology practice.

AB - Scientific advances have significantly improved the practice of medicine by providing objective and quantitative means for exploring the human body and disease states. These innovative technologies have already profoundly improved disease detection, imaging, treatment and patient follow-up. Today's analytical limits are at the nanoscale level (one-billionth of a meter) enabling a detailed exploration at the level of DNA, RNA, proteins and metabolites which are in fact nano-objects. This translational review aims at integrating some recent advances from micro- and nano-technologies with high potential for improving daily oncology practice.

KW - Nanomedicine

KW - circulating tumour cell

KW - nanoparticle

KW - EPR effect

KW - CIRCULATING TUMOR-CELLS

KW - METASTATIC BREAST-CANCER

KW - RESISTANT PROSTATE-CANCER

KW - GENE-EXPRESSION

KW - DRUG-DELIVERY

KW - SOLID TUMORS

KW - MICROFLUIDIC DEVICES

KW - DIAGNOSTIC MARKER

KW - ADHESION MOLECULE

KW - PEPTIDE APTAMERS

U2 - 10.2174/156652410792630634

DO - 10.2174/156652410792630634

M3 - Article

C2 - 20712588

SN - 1566-5240

VL - 10

SP - 640

EP - 652

JO - Current Molecular Medicine

JF - Current Molecular Medicine

IS - 7

ER -

From nanotechnology to nanomedicine: applications to cancer research

Abstract

Keywords

Access to Document

Fingerprint

Cite this